• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Donor Corneal Transplantation vs Boston Type 1 Keratoprosthesis in Patients with Previous Graft Failures: A Retrospective Single Center Study (An American Ophthalmological Society Thesis).既往移植失败患者的供体角膜移植术与波士顿1型人工角膜移植术对比:一项回顾性单中心研究(美国眼科学会论文)
Trans Am Ophthalmol Soc. 2015;113:T3.
2
Boston Type 1 Keratoprosthesis versus Repeat Donor Keratoplasty for Corneal Graft Failure: A Systematic Review and Meta-analysis.波士顿 1 型角膜性角膜成形术与重复供体角膜移植治疗角膜移植失败的比较:系统评价和荟萃分析。
Ophthalmology. 2016 Jan;123(1):165-77. doi: 10.1016/j.ophtha.2015.09.028. Epub 2015 Nov 4.
3
Outcomes of the Boston Type I Keratoprosthesis as the Primary Penetrating Corneal Procedure.作为初次穿透性角膜手术的波士顿I型人工角膜的治疗效果。
Cornea. 2018 Nov;37(11):1400-1407. doi: 10.1097/ICO.0000000000001735.
4
Predictors of visual outcomes following Boston type 1 keratoprosthesis implantation.波士顿1型人工角膜植入术后视觉预后的预测因素。
Am J Ophthalmol. 2015 Apr;159(4):739-47. doi: 10.1016/j.ajo.2014.12.024. Epub 2014 Dec 30.
5
Glaucoma associated with Boston type I keratoprosthesis.与 Boston Ⅰ型角膜移植术相关的青光眼。
Cornea. 2012 Feb;31(2):134-9. doi: 10.1097/ICO.0b013e31820f7a32.
6
Boston type 1 keratoprosthesis: the CHUM experience.波士顿 1 型角膜假体:CHUM 经验。
Can J Ophthalmol. 2011 Apr;46(2):164-8. doi: 10.3129/i10-103.
7
The Boston type I keratoprosthesis: improving outcomes and expanding indications.波士顿I型人工角膜:改善治疗效果并扩大适应证
Ophthalmology. 2009 Apr;116(4):640-51. doi: 10.1016/j.ophtha.2008.12.058. Epub 2009 Feb 25.
8
The Boston Keratoprosthesis type 1 as primary penetrating corneal procedure.波士顿1型人工角膜作为初次穿透性角膜手术。
Br J Ophthalmol. 2015 Dec;99(12):1664-8. doi: 10.1136/bjophthalmol-2014-306161. Epub 2015 Jun 1.
9
Boston Type 1 Keratoprosthesis for Iridocorneal Endothelial Syndromes.用于虹膜角膜内皮综合征的波士顿1型人工角膜
Cornea. 2015 Nov;34(11):1383-6. doi: 10.1097/ICO.0000000000000616.
10
Boston type 1 keratoprosthesis for failed keratoplasty.用于角膜移植失败的波士顿1型人工角膜
Int Ophthalmol. 2016 Feb;36(1):73-78. doi: 10.1007/s10792-015-0078-2. Epub 2015 May 16.

引用本文的文献

1
Artificial Intelligence Aided Analysis of Anterior Segment Optical Coherence Tomography Imaging to Monitor the Device-Cornea Joint After Synthetic Cornea Implantation.人工智能辅助分析眼前节光学相干断层扫描成像以监测人工角膜植入术后的装置-角膜连接情况
Transl Vis Sci Technol. 2025 Jun 2;14(6):1. doi: 10.1167/tvst.14.6.1.
2
Design and Biocompatibility of a Novel, Flexible Artificial Cornea.新型柔韧人工角膜的设计与生物相容性
Transl Vis Sci Technol. 2024 May 1;13(5):19. doi: 10.1167/tvst.13.5.19.
3
Seeing the Future: A Review of Ocular Therapy.展望未来:眼部治疗综述
Bioengineering (Basel). 2024 Feb 13;11(2):179. doi: 10.3390/bioengineering11020179.
4
Semi-Autologous Corneal Transplantation with Simultaneous Bilateral Surgery: A Case Report.双侧同时进行的半自体角膜移植术:一例报告
Case Rep Ophthalmol. 2023 Sep 12;14(1):439-447. doi: 10.1159/000531990. eCollection 2023 Jan-Dec.
5
Twelve-Month Clinical and Histopathological Performance of a Novel Synthetic Cornea Device in Rabbit Model.新型合成角膜装置在兔模型中的 12 个月临床和组织病理学性能。
Transl Vis Sci Technol. 2023 Aug 1;12(8):9. doi: 10.1167/tvst.12.8.9.
6
The treatment of end-stage corneal disease: penetrating keratoplasty compared with Boston type 1 keratoprosthesis.终末期角膜疾病的治疗:穿透性角膜移植术与波士顿 1 型角膜假体的比较。
Graefes Arch Clin Exp Ophthalmol. 2022 Sep;260(9):2781-2790. doi: 10.1007/s00417-022-05646-1. Epub 2022 Apr 6.
7
Artificial corneas versus donor corneas for repeat corneal transplants.用于重复角膜移植的人工角膜与供体角膜对比
Cochrane Database Syst Rev. 2020 May 13;5(5):CD009561. doi: 10.1002/14651858.CD009561.pub3.
8
Marine Collagen as A Promising Biomaterial for Biomedical Applications.海洋胶原蛋白作为一种有前途的生物医用材料。
Mar Drugs. 2019 Aug 10;17(8):467. doi: 10.3390/md17080467.

本文引用的文献

1
Artificial corneas versus donor corneas for repeat corneal transplants.用于重复角膜移植的人工角膜与供体角膜对比
Cochrane Database Syst Rev. 2014 Nov 5;11(11):CD009561. doi: 10.1002/14651858.CD009561.pub2.
2
Long-term outcomes of boston type 1 keratoprosthesis implantation: a retrospective multicenter cohort.Boston 1 型角膜移植术的长期疗效:回顾性多中心队列研究。
Ophthalmology. 2014 Nov;121(11):2159-64. doi: 10.1016/j.ophtha.2014.05.030. Epub 2014 Jul 11.
3
Clinical outcome of repeat penetrating keratoplasty.重复穿透性角膜移植术的临床结果。
Cornea. 2013 Jul;32(7):1026-30. doi: 10.1097/ICO.0b013e31828a2810.
4
Retention of the Boston keratoprosthesis type 1: multicenter study results.Boston 角膜假体 1 型的保留:多中心研究结果。
Ophthalmology. 2013 Jun;120(6):1195-200. doi: 10.1016/j.ophtha.2012.11.025. Epub 2013 Mar 15.
5
International results with the Boston type I keratoprosthesis.波士顿 I 型角膜假体的国际结果。
Ophthalmology. 2012 Aug;119(8):1530-8. doi: 10.1016/j.ophtha.2012.02.015. Epub 2012 Apr 17.
6
Risk factors for the development of retroprosthetic membranes with Boston keratoprosthesis type 1: multicenter study results.Boston 角膜假体 1 型术后发生假体后膜的危险因素:多中心研究结果。
Ophthalmology. 2012 May;119(5):951-5. doi: 10.1016/j.ophtha.2011.11.030. Epub 2012 Feb 22.
7
Boston type 1 keratoprosthesis: the New York Eye and Ear experience.波士顿 1 型角膜假体:纽约眼耳的经验。
Eye (Lond). 2012 Mar;26(3):418-25. doi: 10.1038/eye.2011.325. Epub 2011 Dec 16.
8
Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis.加州大学戴维斯分校波士顿 1 型角膜假体的长期视力结果和并发症。
Ophthalmology. 2011 Aug;118(8):1543-50. doi: 10.1016/j.ophtha.2010.12.032. Epub 2011 Mar 12.
9
Expanding application of the Boston type I keratoprosthesis due to advances in design and improved post-operative therapeutic strategies.由于设计的进步和术后治疗策略的改进,波士顿I型人工角膜的应用正在扩大。
Semin Ophthalmol. 2010 Sep-Nov;25(5-6):239-43. doi: 10.3109/08820538.2010.518895.
10
Third or greater penetrating keratoplasties: indications, survival, and visual outcomes.三次或以上穿透性角膜移植术:适应证、存活率和视力结果。
Cornea. 2010 Mar;29(3):254-9. doi: 10.1097/ICO.0b013e3181b31b6f.

既往移植失败患者的供体角膜移植术与波士顿1型人工角膜移植术对比:一项回顾性单中心研究(美国眼科学会论文)

Donor Corneal Transplantation vs Boston Type 1 Keratoprosthesis in Patients with Previous Graft Failures: A Retrospective Single Center Study (An American Ophthalmological Society Thesis).

作者信息

Akpek Esen K, Cassard Sandra D, Dunlap Karen, Hahn Sarah, Ramulu Pradeep Y

机构信息

Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland.

出版信息

Trans Am Ophthalmol Soc. 2015;113:T3.

PMID:26538773
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4601904/
Abstract

PURPOSE

To compare short-term outcomes of repeat penetrating keratoplasty (PK) to those of Boston type 1 keratoprosthesis (KPro). Our hypothesis was that visual outcomes were superior for KPro compared to PK.

METHODS

This is a retrospective, nonrandomized, intermediate-term case series. Consecutive adults with one or more failed PKs who underwent either PK or KPro between January 2008 and December 2010 were included. Demographics, indication for the initial PK, comorbidities, concomitant procedures, and complications were considered. Only one procedure in each eye was included. All KPro procedures were retained in the analyses.

RESULTS

Fifty-three patients underwent PK and 27 received KPro. Mean follow-up was 19.5 months in the PK group and 16.5 months in the KPro group. KPro eyes had worse mean preoperative vision (hand motions vs counting fingers, P=.01) and more comorbidities. In the postoperative period, 35% of PK eyes and 45% of KPro eyes attained best-ever visual acuity of 20/70. Forty-seven percent of PK eyes vs 40% of KPro eyes were able to retain this visual acuity. Two-year rate of failure to retain visual acuity better than the baseline was higher for PK eyes, though not at a statistically significant level (hazard ratio [HR]=1.67; 95% CI, 0.78-3.60; P=.19). Two-year cumulative rate of graft failure (loss of clarity for PK and removal/replacement for KPro) was higher for PK eyes (HR=3.23; 95% CI, 1.12-9.28; P=.03). Retinal detachment, endophthalmitis, and glaucoma rates were similar (P=.6 for all).

CONCLUSIONS

These results demonstrate less frequent graft failure, greater visual improvement, and greater likelihood of maintaining the visual improvement in KPro eyes vs PK.

摘要

目的

比较重复穿透性角膜移植术(PK)与波士顿1型人工角膜(KPro)的短期疗效。我们的假设是,与PK相比,KPro的视觉效果更佳。

方法

这是一项回顾性、非随机、中期病例系列研究。纳入2008年1月至2010年12月期间接受过一次或多次PK失败后又接受PK或KPro的连续成年患者。考虑人口统计学、初次PK的指征、合并症、同期手术及并发症。每只眼仅纳入一次手术。所有KPro手术均纳入分析。

结果

53例患者接受了PK,27例接受了KPro。PK组平均随访19.5个月,KPro组平均随访16.5个月。KPro组患眼术前平均视力较差(手动视力与数指视力,P = 0.01)且合并症更多。术后,35%的PK组患眼和45%的KPro组患眼达到了20/70的最佳矫正视力。47%的PK组患眼与40%的KPro组患眼能够维持这一视力。PK组患眼未能维持优于基线视力的两年失败率更高,尽管未达到统计学显著水平(风险比[HR]=1.67;95%可信区间,0.78 - 3.60;P = 0.19)。PK组患眼的两年移植失败累积率(PK为失去透明度,KPro为取出/更换)更高(HR = 3.23;95%可信区间,1.12 - 9.28;P = 0.03)。视网膜脱离、眼内炎和青光眼发生率相似(所有P值均为0.6)。

结论

这些结果表明,与PK相比,KPro组患眼的移植失败频率更低、视觉改善更大且维持视觉改善的可能性更大。